Gary E Anderson, CRNA | |
353 Fairmont Blvd, Rapid City, SD 57701-7375 | |
(605) 719-1000 | |
(605) 719-7680 |
Full Name | Gary E Anderson |
---|---|
Gender | Male |
Speciality | Nurse Anesthetist, Certified Registered |
Location | 353 Fairmont Blvd, Rapid City, South Dakota |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124135413 | NPI | - | NPPES |
4994755 | Other | SD | WELLMARK |
5752123 | Medicaid | SD | |
5752124 | Medicaid | SD | |
P00246259 | Other | SD | RR MEDICARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367500000X | Nurse Anesthetist, Certified Registered | R023263 (South Dakota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Gary E Anderson, CRNA Po Box 3450, Rapid City, SD 57709-3450 Ph: (605) 719-1000 | Gary E Anderson, CRNA 353 Fairmont Blvd, Rapid City, SD 57701-7375 Ph: (605) 719-1000 |
News Archive
Optimer Pharmaceuticals, Inc. today reported financial results for the second quarter ended June 30, 2010. Optimer reported a net loss for the second quarter of 2010 of $10.4 million, or $0.27 per share, which was in line with the Company's expectations. This compares to a net loss for the second quarter of 2009 of $12.4 million, or $0.37 per share. The decrease in net loss was primarily due to lower research and development expenses offset by an increase in general and administrative expenses.
Today, Monday 30th June, 2014, Isogenica, Cambridge UK and Imperial College London secure funding from the Technology Strategy Board (TSB), the UK's innovation agency, for a £347,000 project to optimise a gene library assembly technology for potential use in synthetic biology.
Jazz Pharmaceuticals plc today announced that the U.S. Food and Drug Administration approved the intravenous administration of Erwinaze (asparaginase Erwinia chrysanthemi). Erwinaze is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia (ALL) who have developed hypersensitivity to E. coli-derived asparaginase.
GN Hearing today unveils the world's first Premium-Plus hearing aid: ReSound LiNX Quattro, designed for people who want the very best that technology has to offer and desire a brilliant sound experience with great speech intelligibility even in noisy situations.
Abuse often leads to depression and medical problems in older patients — even death within a year of an abusive incident.
› Verified 8 days ago
Dawn Jo Zastoupil, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 353 Fairmont Blvd, Rapid City, SD 57501 Phone: 605-755-1000 | |
Patrick Staedtler, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 353 Fairmont Blvd, Rapid City, SD 57701 Phone: 605-755-1000 | |
Joseph W Amo, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 353 Fairmont Blvd, Rapid City, SD 57701 Phone: 605-719-1000 | |
Jessica Anne Newman, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 353 Fairmont Blvd, Rapid City, SD 57701 Phone: 605-719-1000 | |
Karen A Bryant, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 353 Fairmont Blvd., Rapid City, SD 57701 Phone: 605-719-1000 | |
Mr. Peter Schwiesow, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 216 Anamaria Dr, Rapid City, SD 57701 Phone: 606-721-4700 | |
Katie Kristine Bates, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 353 Fairmont Blvd, Rapid City, SD 57701 Phone: 605-719-1000 Fax: 605-719-7884 |